The COVID-19 pandemic has hurt the effort of colorectal cancer screenings.
The recent change in guidance to reduce the recommended age of universal colorectal cancer screenings from 50 to 45 for low-risk individuals might have a drastic impact on early cancer detection.
However, that impact might be minimized by the ongoing COVID-19 pandemic.
One of the biggest issues that has stemmed from the pandemic is a lot of preventative medicine was ignored and forgotten.
And despite a major public awareness campaign to increase colorectal cancer screenings, the pandemic did set things back a bit.
In an interview with HCPLive®, Aasma Shaukat, MD, MPH, Director of Research Outcomes, Division of Gastroenterology and Hepatology, NYU Langone, explained how damaging the pandemic was toward the goal of 80% colorectal cancer screenings for individuals aged 45 years and older.
Shaukat appeared during the 2022 American College of Gastroenterology (ACG) Annual Meeting in Charlotte.
Shaukat also said there remains a need for new research into identifying and categorizing risk factors for colon cancer.
She also said developing a grading system or a score would go a long way toward separating who should be screened at an earlier age and who could wait until they are 45.